Drugs & TargetsFree Atezolizumab + bevacizumab approved by FDA for unresectable HCC June 05, 2020Vol.46 No.23
Drugs & TargetsFree Ramucirumab + erlotinib approved by FDA for first-line metastatic NSCLC June 05, 2020Vol.46 No.23
Drugs & TargetsFree Piqray receives positive CHMP opinion to treat HR+/HER2- advanced breast cancer with a PIK3CA mutation June 05, 2020Vol.46 No.23
Drugs & TargetsFree Sarclisa approved by European Commission for adults with relapsed and refractory multiple myeloma June 05, 2020Vol.46 No.23
Drugs & TargetsFree Subcutaneous formulation of Darzalex approved by EC for multiple myeloma June 05, 2020Vol.46 No.23
Clinical RoundupFree ACS study defines lost earnings for black cancer patients June 05, 2020Vol.46 No.23
Clinical RoundupFree Keytruda monotherapy significantly reduces risk of disease progression, death in colorectal cancer June 05, 2020Vol.46 No.23
Clinical RoundupFree Xtandi significantly extends OS in men with non-metastatic CRPC June 05, 2020Vol.46 No.23
